Corcept Therapeutics Inc. (CORT)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

35

0

3

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Apr-24 7:00 PM View:	10-Apr-24 Disposition (other) 0	Mahoney David L Director		Corcept Therapeutics Inc. - CORT	2% 1.26M to 1.29M	0	0	--	--	Show Txns Hide Txns

03-Apr-24 7:38 PM View:	01-Apr-24 Planned Option Sale ($55.66K)	Swisher Daniel N Jr Director		Corcept Therapeutics Inc. - CORT	0% --	0	0	--	--	Show Txns Hide Txns

05-Mar-24 9:03 PM View:	01-Mar-24 Payment of Exercise ($12.44K)	Mokari Atabak Chief Financial Officer		Corcept Therapeutics Inc. - CORT	7% 8.95K to 9.54K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 8:41 PM View:	01-Mar-24 Payment of Exercise ($15.78K)	Robb Gary Charles Chief Business Officer		Corcept Therapeutics Inc. - CORT	3% 28.16K to 28.9K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 9:09 PM View:	01-Mar-24 Payment of Exercise ($14.53K)	Guyer William Chief Development Officer		Corcept Therapeutics Inc. - CORT	(9%) 6.64K to 6.04K	0	0	--	--	Show Txns Hide Txns

29-Mar-24 2:12 PM View:	27-Mar-24 Planned Option Sale ($649.02K)	Maduck Sean See Remarks		Corcept Therapeutics Inc. - CORT	11% 94.45K to 105.22K	0	0	--	--	Show Txns Hide Txns

08-Apr-24 6:16 PM View:	04-Apr-24 Planned Option Sale ($141.52K)	Lyon Joseph Douglas See Remarks		Corcept Therapeutics Inc. - CORT	8% 6.77K to 7.31K	0	0	--	--	Show Txns Hide Txns